On February 22, Gao Yan and Gao Haiyue, deputy directors of the Management Committee of Beijing Daxing Biomedical Industry Base, Sun Chao, director of the two district offices, Tang Jingchuan, head of the talent section of the Organization Department of the Daxing District Party Committee, and the working group of the Shenzhen Station of Daxing District, as well as Wang Huifang, secretary-general of the Shenzhen Pingshan High-level Talents Association, visited Shenzhen Cell Valley. Shi Yuanyuan, Chairman of Shenzhen Cell Valley Bio-pharmaceutical Co., Ltd., Wei Zheng, Assistant Chairman of the Board, Luan Zhishi, Director of the General Office, and Fu Yuchen, scientist of the R&D Department, received warmly. On February 22, Gao Yan and Gao Haiyue, deputy directors of the Management Committee of Beijing Daxing Biomedical Industry Base, Sun Chao, director of the two district offices, Tang Jingchuan, head of the talent section of the Organization Department of the Daxing District Party Committee, and the working group of the Shenzhen Station of Daxing District, as well as Wang Huifang, secretary-general of the Shenzhen Pingshan High-level Talents Association, visited Shenzhen Cell Valley. Shi Yuanyuan, Chairman of Shenzhen Cell Valley Bio-pharmaceutical Co., Ltd., Wei Zheng, Assistant Chairman of the Board, Luan Zhishi, Director of the General Office, and Fu Yuchen, scientist of the R&D Department, received warmly. At the symposium, Chairman Shi Yuanyuan introduced the basic status quo, construction intention, development process, core team and comprehensive strength of Shenzhen Cell Valley; Gao Yan, Gao Haiyue, deputy director of the management committee of Daxing Bio-pharmaceutical Industrial Base, and Tang Jingchuan, head of the talent section of the organization department of Daxing District Party Committee of Beijing, affirmed the achievements of Shenzhen Cell Valley in the field of cell and gene therapy, and gave a detailed explanation of the innovation and industrial policy and industrial planning of Daxing Bio-pharmaceutical Industrial Base. The two sides held in-depth discussions on talent incentives, the development characteristics of industries in Beijing and Shenzhen, and the development trend of cell and gene therapy industries. Professor Shi Yuanyuan said that the strategic layout of core areas such as Beijing is an extremely important part of the development of Shenzhen Cell Valley. The joint construction of the development platform for cell and gene therapy professionals is the key driving force to promote research and development and create a new business form. The two sides said that they would take this exchange visit as an opportunity to establish further cooperation and exchange, combine the industrial policy of Daxing District of Beijing, promote the transformation of biomedical scientific research achievements, and jointly promote the high-quality development of the biomedical industry.